Cochrane · systematic review · CD013122

Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis

Plaz Torres, MCorina, Best, LMJ, Freeman, SC, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
40
current version
GRADE rated
38
No studies
2
Included studies
NR
No studies 2 · 5%Ungraded 0 · 0%Very low 8 · 20%Low 23 · 57.5%Moderate 7 · 17.5%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis (all interventions)

Population: people with liver cirrhosis and previous oesophageal variceal bleeding
40 questions
OutcomeEffectEvidenceStatus / GRADE
Interventions
no estimate extractedNRNo studies
Sclerotherapy
no estimate extractedNRNo studies
Beta‐blockers(9 RCTs; 493 participants)
HR 0.88 [0.66, 1.18]NRLow
Downgraded: risk of bias, imprecision
Variceal band ligation(5 RCTs; 399 participants)
HR 0.95 [0.62, 1.46]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Sclerotherapy(8 RCTs; 370 participants)
HR 0.69 [0.43, 1.09]NRLow
Downgraded: risk of bias, imprecision
No active intervention(4 RCTs; 412 participants)
HR 1.2 [0.83, 1.84]NRLow
Downgraded: risk of bias, imprecision
TIPS(3 RCTs; 189 participants)
HR 0.94 [0.56, 1.59]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Nitrates(No direct RCT)
HR 0.91 [0.53, 1.58]NRLow
Downgraded: risk of bias, imprecision
Portocaval shunt(2 RCTs; 100 participants)
HR 1.21 [0.68, 2.15]NRLow
Downgraded: risk of bias, imprecision
Sclerotherapy plus Variceal band ligation(No direct RCT)
HR 0.78 [0.35, 1.76]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Nitrates plus Variceal band ligation(No direct RCT)
HR 0.89 [0.4, 1.98]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Variceal band ligation(No direct RCT)
HR 0.83 [0.22, 3.05]NRLow
Downgraded: risk of bias, imprecision
Sclerotherapy plus Nitrates(1 RCT; 76 participants)
HR 0.19 [0.02, 0.86]NRModerate
Downgraded: risk of bias
Beta‐blockers(1 RCT; 91 participants)
OR 0.47 [0.13, 1.53]NRVery low
Downgraded: risk of bias, imprecision
Variceal band ligation(1 RCT; 100 participants)
OR 0.19 [0.06, 0.53]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Sclerotherapy(No direct RCT)
OR 1.29 [0.28, 5.7]NRVery low
Downgraded: risk of bias, imprecision
Beta‐blockers(No direct RCT)
OR 11.86 [1.16, 427.95]NRLow
Downgraded: risk of bias, imprecision
Variceal band ligation(3 RCTs; 215 participants)
OR 0.39 [0.16, 1.09]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus Sclerotherapy(2 RCTs; 71 participants)
OR 1.46 [0.36, 6.06]NRLow
Downgraded: risk of bias, imprecision
No active intervention(1 RCT; 40 participants)
OR 0.22 [0.05, 0.86]NRLow
Downgraded: risk of bias, imprecision
TIPS(No direct RCT)
OR 0.02 [0, 0.17]NRLow
Downgraded: risk of bias, imprecision
Variceal band ligation(2 RCTs; 188 participants)
Rate ratio 0.4 [0.26, 0.61]NRModerate
Downgraded: risk of bias
Beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants)
Rate ratio 0.93 [0.68, 1.26]NRLow
Downgraded: risk of bias, imprecision
TIPS(1 RCT; 63 participants)
Rate ratio 1.1 [0.73, 1.66]NRLow
Downgraded: risk of bias, imprecision
Portocaval shunt(1 RCT; 45 participants)
Rate ratio 0.87 [0.34, 2.28]NRLow
Downgraded: risk of bias, imprecision
Variceal band ligation(1 RCT; 111 participants)
HR 0.94 [0.03, 35.27]NRVery low
Downgraded: risk of bias, imprecision
Beta‐blockers plus Sclerotherapy(1 RCT; 40 participants)
HR 1.26 [0.17, 10.1]NRVery low
Downgraded: risk of bias, imprecision
TIPS(1 RCT; 80 participants)
HR 1.52 [0.39, 6.6]NRVery low
Downgraded: risk of bias, imprecision
Beta‐blockers(1 RCT; 28 participants)
HR 0.46 [0, 43.25]NRVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
No active intervention(No direct RCT)
HR 1.19 [0, 1726.76]NRVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Beta‐blockers(6 RCTs; 420 participants)
HR 1.62 [1.14, 2.38]NRModerate
Downgraded: risk of bias
Variceal band ligation(2 RCTs; 111 participants)
HR 1.61 [0.72, 3.77]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers plus sclerotherapy(4 RCTs; 231 participants)
HR 0.6 [0.37, 0.95]NRModerate
Downgraded: risk of bias
No active intervention(3 RCTs; 296 participants)
HR 1.61 [1.01, 2.86]NRModerate
Downgraded: risk of bias
TIPS(2 RCTs; 109 participants)
HR 0.18 [0.08, 0.38]NRModerate
Downgraded: risk of bias
Beta‐blockers plus nitrates(No direct RCT)
HR 2.13 [0.79, 5.86]NRLow
Downgraded: risk of bias, imprecision
Portocaval shunt(No direct RCT)
HR 0.21 [0.05, 0.77]NRModerate
Downgraded: risk of bias
Sclerotherapy plus variceal band ligation(No direct RCT)
HR 1.83 [0.46, 7.4]NRLow
Downgraded: risk of bias, imprecision
Beta‐blockers(1 RCT; 65 participants)
Rate ratio 2.4 [1.35, 4.55]NRLow
Downgraded: risk of bias, imprecision
Variceal band ligation(No direct RCT)
Rate ratio 1.92 [0.31, 10.62]NRVery low
Downgraded: risk of bias, imprecision